Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.42 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.42 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.42 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.42 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.42 |
| ▸ | MTOR | P42345 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.42 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.42 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21548130 | 0.81 | LMNA (0.52) | LMNAGRIN1GRIN2ASLC22A1GRIN2D | |
| SCHEMBL14385368 | 0.75 | LMNA (0.35) | LMNAGRIN1GRIN2ASLC22A1GRIN2D | |
| SCHEMBL14385021 | 0.74 | LMNA (0.41) | LMNAGRIN1GRIN2ASLC22A1GRIN2D | |
| SCHEMBL14385290 | 0.73 | LMNA (0.39) | LMNAGRIN1GRIN2ASLC22A1GRIN2D | |
| SCHEMBL21298754 | 0.73 | — | — | |
| SCHEMBL7922215 | 0.72 | — | — | |
| SCHEMBL7928095 | 0.72 | — | — | |
| SCHEMBL8227711 | 0.72 | — | — | |
| SCHEMBL13699365 | 0.69 | GRIN2D (0.33) | GRIN1GRIN2AGRIN2DGRIN3BGRIN2B | |
| SCHEMBL3671265 | 0.68 | LMNA (0.38) | LMNAGRIN1GRIN2ASLC22A1GRIN2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010083996-A1 | A PROCESS FOR PREPARING MEMANTINE | MERZ PHARMA GMBH & CO. KGAA (DE) | 2010-07-29 | — | — | WO | disclosed |
| WO-2010015415-A1 | PROCESS FOR MANUFACTURING ADAMANTANE DERIVATIVES WITH HIGH YIELD | MERZ PHARMA GMBH & CO. KGAA (DE) | 2010-02-11 | — | — | WO | disclosed |
| WO-2009115334-A2 | PROCESS FOR THE MANUFACTURE OF MEMANTINE AND INTERMEDIATE PRODUCT | MERZ PHARMA GMBH & CO. KGAA (DE) | 2009-09-24 | — | — | WO | disclosed |
| WO-2008063847-A2 | METHOD FOR TREATING AUTISM | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2008-05-29 | — | — | WO | disclosed |
| EP-1886670-A1 | Pharmaceutical compositions of memantine | Teva Pharmaceutical Industries Ltd (IL) | 2008-02-13 | — | — | EP | disclosed |
| WO-2007132476-A2 | A PROCESS FOR THE PREPARATION OF MEMANTINE HYDROCHLORIDE | MATRIX LABORATORIES LIMITED (IN) | 2007-11-22 | — | — | WO | disclosed |
| WO-2007096124-A1 | PROCESS FOR THE PREPARATION OF ADAMANTANAMINES | HEXAL AG (DE) | 2007-08-30 | — | — | WO | disclosed |
| WO-2005070429-A1 | PHARMACEUTICAL COMPOSITION COMPRISING A MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITOR AND AN N-METHYL-D-ASPARTATE (NMDA) RECEPTORS ANTAGONIST | NEUROSEARCH A/S (DK) | 2005-08-04 | — | — | WO | disclosed |